Pharmacists can make a big difference to the lives of people with diabetes, says credentialled diabetes educator (CDE) Jayne Lehmann.
“They can pick up a lot about a person from the products they buy,” which, she says, can be “a red flag to check for hypoglycaemia and potential intervention”. Indeed, she refers to pharmacists as “diabetes detectives”.
The articles published in the Diabetes Focus section of AJP.com.au include a profile the pioneering work of Lehmann and Kirrily Chambers, Australia’s first pharmacist–CDE, and the support they provide to people with diabetes, including those with disabilities.
They share the strategies they use they use to improve the lives of people with diabetes, and explain why the language we use around the condition is vitally important too.
We take a look at the latest diabetes practice and research, including an update on the much-anticipated Pharmacy Diabetes Screening Trial, as well as treatment breakthroughs including the use of drugs to delay or slow the onset of type 1 diabetes, such as with the use of teplizumab.
On the topic of new therapies, the CPD accredited article. Glucagon-like peptide-1 receptor agonists for type 2 diabetes, focuses on the use of GLP-1 receptor agonists in type 2 diabetes and the role of pharmacy.
And we lift the lid on a relatively new area—psychological insulin resistance and how you can help your patients struggling with the idea starting insulin.
We hope you enjoy reading our in-depth focus on diabetes and that it helps you to refresh your thinking about ways to connect with your patients in the prevention, detection and management of the disease.